Like other CRC PDXs, our CRC PDXs were found to harbor wild type KRAS, which is not common in traditional CRC cell lines, which will be highly advantageous for pre-clinical studies in cetuximab resistance, for example [38,75,76]. Here, KRAS is linked to colorectal carcinoma.